Detection of Alveolar Fibrocytes in Idiopathic Pulmonary Fibrosis and Systemic Sclerosis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Borie, Raphael ^a,b   Quesnel, Christophe ^b,c   Phin, Sophie ^b   Debray, Marie Pierre ^a   Marchal Somme, Joelle ^b   Tiev, Kiet ^d   Bonay, Marcel ^b,d,e   Fabre, Aurélie ^a,b,e   Soler, Paul ^b   Dehoux, Monique ^a,b   Crestani, Bruno ^a,b,e  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

^c HÔPITAL TENON   (France)

^d HÔPITAL SAINT ANTOINE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONNECTIVE TISSUE CELL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROBLAST CULTURE; FIBROCYTE; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; PREDICTION; PROGNOSIS; QUANTITATIVE ANALYSIS; SYSTEMIC SCLEROSIS;

AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE; CELL COUNT; FEMALE; FIBROBLASTS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; PULMONARY ALVEOLI; SCLERODERMA, SYSTEMIC; TIME FACTORS;

EID: 84872463518     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053736     Document Type: Article

References (30)

1. Lama VN, Phan SH, (2006) The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. Proc Am Thorac Soc 3: 373-376.
2. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, et al. (2009) Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 179: 588-594.
3. Hashimoto N, Jin H, Liu T, Chensue SW, Phan SH, (2004) Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113: 243-252.
4. Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A, (1994) Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1: 71-81.
5. Metz CN, (2003) Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 60: 1342-1350.
6. Mattoli S, Bellini A, Schmidt M, (2009) The Role of a Human Hematopoietic Mesenchymal Progenitor in Wound Healing and Fibrotic Diseases and Implications for Therapy. Curr Stem Cell Res Ther. 4: 266-80.
7. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, et al. (2005) CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 166: 675-684.
8. Pilling D, Roife D, Wang M, Ronkainen SD, Crawford JR, et al. (2007) Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P. J Immunol. 179: 4035-4044.
9. Tourkina E, Bonner M, Oates J, Hofbauer A, Richard M, et al. (2011) Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair 4: 15.
10. Quesnel C, Piednoir P, Gelly J, Nardelli L, Garnier M, et al. (2012) Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury. Crit Care Med. 40: 21-8.
11. Quesnel C, Marchand-Adam S, Fabre A, Marchal-Somme J, Philip I, et al. (2008) Regulation of hepatocyte growth factor secretion by fibroblasts in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 294: L334-343.
12. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664.
13. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, et al. (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824.
14. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23: 581-590.
15. Kazerooni EA, Martinez FJ, Flint A, Jamadar DA, Gross BH, et al. (1997) Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 169: 977-983.
16. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, et al. (2007) Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 176: 636-643.
17. Ley B, Collard HR, King TE Jr, (2011) Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183: 431-440.
18. Quesnel C, Nardelli L, Piednoir P, Lecon V, Marchal-Somme J, et al. (2010) Alveolar fibroblasts in acute lung injury: biological behaviour and clinical relevance. Eur Respir J 35: 1312-1321.
19. Reilkoff RA, Bucala R, Herzog EL, (2011) Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 11: 427-435.
20. Fujiwara A, Kobayashi H, Masuya M, Maruyama M, Nakamura S, et al. (2012) Correlation between circulating fibrocytes and activity and progression of interstitial lung diseases. Respirology. 17: 693-8.
21. Gan Y, Reilkoff R, Peng X, Russell T, Chen Q, et al. (2011) Role of semaphorin 7a signaling in transforming growth factor beta1-induced lung fibrosis and scleroderma-related interstitial lung disease. Arthritis Rheum 63: 2484-2494.
22. Andersson-Sjoland A, de Alba CG, Nihlberg K, Becerril C, Ramirez R, et al. (2008) Fibrocytes are a potential source of lung fibroblasts in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol 40: 2129-2140.
23. Mattoli S, Bellini A, Schmidt M, (2009) The role of a human hematopoietic mesenchymal progenitor in wound healing and fibrotic diseases and implications for therapy. Curr Stem Cell Res Ther 4: 266-280.
24. Maharaj SS, Baroke E, Gauldie J, Kolb MR, (2012) Fibrocytes in chronic lung disease- Facts and controversies. Pulm Pharmacol Ther 25: 263-267.
25. Marchal-Somme J, Uzunhan Y, Marchand-Adam S, Kambouchner M, Valeyre D, et al. (2007) Dendritic cells accumulate in human fibrotic interstitial lung disease. Am J Respir Crit Care Med 176: 1007-1014.
26. Medina A, Ghahary A, (2010) Fibrocytes can be reprogrammed to promote tissue remodeling capacity of dermal fibroblasts. Mol Cell Biochem 344: 11-21.
27. Valenzuela-Fernandez A, Planchenault T, Baleux F, Staropoli I, Le-Barillec K, et al. (2002) Leukocyte elastase negatively regulates Stromal cell-derived factor-1 (SDF-1)/CXCR4 binding and functions by amino-terminal processing of SDF-1 and CXCR4. J Biol Chem 277: 15677-15689.
28. Rao RM, Betz TV, Lamont DJ, Kim MB, Shaw SK, et al. (2004) Elastase release by transmigrating neutrophils deactivates endothelial-bound SDF-1alpha and attenuates subsequent T lymphocyte transendothelial migration. J Exp Med 200: 713-724.
29. Lama VN, Smith L, Badri L, Flint A, Andrei AC, et al. (2007) Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest 117: 989-996.
30. Fireman E, Shahar I, Shoval S, Messer G, Dvash S, et al. (2001) Morphological and biochemical properties of alveolar fibroblasts in interstitial lung diseases. Lung 179: 105-117.